Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (1): 83-95     DOI: 10.31083/j.rcm.2021.01.241
Review Previous articles | Next articles
Exploring the impact of the COVID-19 pandemic on provision of cardiology services: a scoping review
Farah Yasmin1, Syed Muhammad Shujauddin1, Aisha Naeem1, Adina Jabeen1, Syed Muhammad Ismail Shah2, Rohan Kumar Ochani1, Osama Mohiuddin1, Anosh Aslam Khan1, Sumeen Jalees1, Aminah Abdul Razzack3, Shiza Salman4, Shuja Abdul Karim Khan1, Ahmad Mustafa5, Hassan Mehmood Lak6, *()
1Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, 247000 Karachi, Pakistan
2Department of Internal Medicine, Ziauddin Medical University, 247000 Karachi, Pakistan
3Dr NTR University of Health Sciences, 502355 Vijayawada, India
4Department of Internal Medicine, Dow International Medical College, 247000 Karachi, Pakistan
5Department of Internal Medicine, Staten Island University Hospital, NY 10001, USA
6Department of Medicine, Cleveland Clinic Foundation, Cleveland, OH 44111, USA
Download:  PDF(378KB)  ( 1610 ) Full text   ( 97 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
The coronavirus disease-19 (COVID-19) pandemic has forced hospitals to prioritize COVID-19 patients, restrict resources, and cancel all non-urgent elective cardiac procedures. Clinical visits have only been facilitated for emergency purposes. Fewer patients have been admitted to the hospital for both ST-segment elevation myocardial infarctions (STEMI) and non-ST segment elevation myocardial infarctions (NSTEMI) and a profound decrease in heart failure services has been reported. A similar reduction in the patient presentation is seen for ischemic heart disease, decompensated heart failure, and endocarditis. Cardiovascular services, including catheterization, primary percutaneous coronary intervention (PPCI), cardiac investigations such as electrocardiograms (ECGs), exercise tolerance test (ETT), dobutamine stress test, computed tomography (CT) angiography, transesophageal echocardiography (TOE) have been reported to have declined and performed on a priority basis. The long-term implications of this decline have been discussed with major concerns of severe cardiac complications and vulnerabilities in cardiac patients. The pandemic has also had psychological impacts on patients causing them to avoid seeking medical help. This review discusses the effects of the COVID-19 pandemic on the provision of various cardiology services and aims to provide strategies to restore cardiovascular services including structural changes in the hospital to make up for the reduced staff personnel, the use of personal protective equipment in healthcare workers, and provides alternatives for high-risk cardiac imaging, cardiac interventions, and procedures. Implementation of the triage system, risk assessment scores, and telemedicine services in patients and their adaptation to the cardiovascular department have been discussed.
Key words:  Coronavirus disease-19 (COVID-19)      Cardiovascular      Primary percutaneous coronary intervention      Cardiac catheterization     
Submitted:  08 November 2020      Revised:  30 December 2020      Accepted:  03 January 2021      Published:  30 March 2021     
*Corresponding Author(s):  Hassan Mehmood Lak     E-mail:  Lakh@ccf.org

Cite this article: 

Farah Yasmin, Syed Muhammad Shujauddin, Aisha Naeem, Adina Jabeen, Syed Muhammad Ismail Shah, Rohan Kumar Ochani, Osama Mohiuddin, Anosh Aslam Khan, Sumeen Jalees, Aminah Abdul Razzack, Shiza Salman, Shuja Abdul Karim Khan, Ahmad Mustafa, Hassan Mehmood Lak. Exploring the impact of the COVID-19 pandemic on provision of cardiology services: a scoping review. Reviews in Cardiovascular Medicine, 2021, 22(1): 83-95.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm.2021.01.241     OR     https://rcm.imrpress.com/EN/Y2021/V22/I1/83

[1] Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Arturo Cesaro, Luca Rinaldi, Teresa Salvatore, Raffaele Marfella, Celestino Sardu, Elisabetta Moscarella, Felice Gragnano, Paolo Calabrò, Ferdinando Carlo Sasso. Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 755-768.
[2] Guinan Xie, An Yan, Peng Lin, Yi Wang, Liping Guo. Trimethylamine N-oxide—a marker for atherosclerotic vascular disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 787-797.
[3] Xiaoqing Zhu, Guanhua Xu, Wangyan Jin, Yingying Gu, Xuhua Huang, Lidan Ge. Apple or apple polyphenol consumption improves cardiovascular disease risk factors: a systematic review and meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 835-843.
[4] Niki Katsiki, Matina Kouvari, Demosthenes B Panagiotakos, Claudio Borghi, Christina Chrysohoou, Dimitri P Mikhailidis, Christos Pitsavos. The association between serum uric acid levels and 10-year cardiovascular disease incidence: results from the ATTICA prospective study[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 991-1001.
[5] Janani Rangaswami. Closing gaps in the care of patients with heart-kidney disease: the time is now[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 257-258.
[6] Lee Stoner, Mark Faghy, Ryan Conners. COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 263-265.
[7] Saeed Shoar, Waleed Ikram, Ahmed Ali Shah, Najam Farooq, Srikanth Gouni, Soheila Khavandi, Elsa Tabibzadeh, Siamak Khavandi. Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 295-299.
[8] Eyad Abuelgasim, Suleyman Shah, Biyaser Abuelgasim, Nikita Soni, Ashvin Thomas, Mustafa Elgasim, Amer Harky. Clinical overview of diabetes mellitus as a risk factor for cardiovascular death[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 301-314.
[9] Ibrahim AlShahrani, Jagadish Hosmani, Vidya Gurram Shankar, Abdulaziz AlShahrani, Rafi Ahmad Togoo, Syed M Yassin, Shahrukh Khan, Shankargouda Patil. COVID-19 and cardiovascular system—a comprehensive review[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 343-351.
[10] Kui Huang, Xiao-Qin Wen, Ning Ren, Li Yang, Bo Gao. Lipidomic profile in patients with a very high risk of atherosclerotic cardiovascular disease on PCSK9 inhibitor therapy[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 461-467.
[11] Yunfeng Xi, Ning Cao, Liwei Niu, Hao Zhu, Han Bao, Liying Qiao, Shuqi Ji, Tao Yan, Xiaoqian Xu, Wenrui Wang, Xingguang Zhang. Prevalence and treatment of high cardiovascular disease risk in Inner Mongolia, China[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 521-529.
[12] Sheng-Li Du, Zeng-Qin Jia, Jiu-Chang Zhong, Le-Feng Wang. TRPC5 in cardiovascular diseases[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 127-135.
[13] Yu-Hao Zhao, Lei Zhao, Xin-Chun Yang, Pan Wang. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 159-165.
[14] Kyriacos Papadopoulos, Arthur Kerner, Sergey Yalonetsky, Eugenia Nikolsky, Yair Feld, Ariel Roguin. Strategies to overcome challenges of transradial coronary angiography and intervention[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 501-505.
[15] Jasjit S. Suri, Anudeep Puvvula, Misha Majhail, Mainak Biswas, Ankush D. Jamthikar, Luca Saba, Gavino Faa, Inder M. Singh, Ronald Oberleitner, Monika Turk, Saurabh Srivastava, Paramjit S. Chadha, Harman S. Suri, Amer M. Johri, Vijay Nambi, J Miguel Sanches , Narendra N. Khanna, Klaudija Viskovic, Sophie Mavrogeni, John R. Laird, Arindam Bit, Gyan Pareek, Martin Miner, Antonella Balestrieri, Petros P. Sfikakis, George Tsoulfas, Athanasios Protogerou, Durga Prasanna Misra, Vikas Agarwal, George D. Kitas, Raghu Kolluri, Jagjit Teji, Michele Porcu, Mustafa Al-Maini, Ann Agbakoba, Meyypan Sockalingam, Ajit Sexena, Andrew Nicolaides, Aditya Sharma, Vijay Rathore, Vijay Viswanathan, Subbaram Naidu, Deepak L. Bhatt. Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence[J]. Reviews in Cardiovascular Medicine, 2020, 21(4): 541-560.
No Suggested Reading articles found!